Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.
Yung
Alison R
AR
Orygen Research Centre and University of Melbourne, Department of Psychiatry, 35 Poplar Rd, Parkville 3052, Victoria, Australia. aryung@unimelb.edu.au
Phillips
Lisa J
LJ
Nelson
Barnaby
B
Francey
Shona M
SM
PanYuen
Hok
H
Simmons
Magenta B
MB
Ross
Margaret L
ML
Kelly
Daniel
D
Baker
Kathryn
K
Amminger
G Paul
GP
Berger
Gregor
G
Thompson
Andrew D
AD
Thampi
Annette
A
McGorry
Patrick D
PD
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D003376:Counseling; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life / Q000523:psychology; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*; D012917:Social Adjustment; D012944:Social Support; D016896:Treatment Outcome; D055815:Young Adult
D014150:Antipsychotic Agents; D018967:Risperidone